TEMPUS PORTER'S FIVE FORCES TEMPLATE RESEARCH B_45 Better Therapeutics faces intense rivalry

Better Therapeutics faces intense rivalry from diverse sources within the healthcare and technology sectors

Switching Costs High costs boost supplier influence Tech integration costs up to $500

They also help manage fleet services

EBITDA margin ~22%

New generative AI applications from Perficient are in the Question Mark quadrant of the BCG Matrix

TEMPUS PORTER'S FIVE FORCES TEMPLATE RESEARCH B_45 Better Therapeutics faces intense rivalryDon't Miss the Bigger Picture Tempus faces intense rivalry from established diagnostics and AI health firms, moderate supplier power due to specialized data needs, growing buyer sophistication, emerging substitutes in decentralized testing, and high threat of new entrants driven by AI tools; this snapshot hints at strategic pressure points and opportunity areas. Unlock the full Porter's Five Forces Analysis to get force by force ratings, visuals, and